Characterization of pomiferin triacetate as a novel mTOR and translation inhibitor
about
Novel cancer chemotherapy hits by molecular topology: dual Akt and Beta-catenin inhibitorsDiaryl Disulfides as Novel Stabilizers of Tumor Suppressor Pdcd4Tricyclic guanidine alkaloids from the marine sponge Acanthella cavernosa that stabilize the tumor suppressor PDCD4.Halofuginone inhibits colorectal cancer growth through suppression of Akt/mTORC1 signaling and glucose metabolism.
P2860
Characterization of pomiferin triacetate as a novel mTOR and translation inhibitor
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 07 February 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Characterization of pomiferin triacetate as a novel mTOR and translation inhibitor
@en
Characterization of pomiferin triacetate as a novel mTOR and translation inhibitor.
@nl
type
label
Characterization of pomiferin triacetate as a novel mTOR and translation inhibitor
@en
Characterization of pomiferin triacetate as a novel mTOR and translation inhibitor.
@nl
prefLabel
Characterization of pomiferin triacetate as a novel mTOR and translation inhibitor
@en
Characterization of pomiferin triacetate as a novel mTOR and translation inhibitor.
@nl
P2093
P2860
P1476
Characterization of pomiferin triacetate as a novel mTOR and translation inhibitor
@en
P2093
Curtis J Henrich
Hanyong Chen
Heidi R Bokesch
James B McMahon
Johanna S Blees
Kirk R Gustafson
Magdalena M Bajer
Michael M Kunze
Nancy H Colburn
Thilo F Brauss
P2860
P304
P356
10.1016/J.BCP.2014.01.034
P407
P577
2014-02-07T00:00:00Z